Anna Verrone

1.2k total citations
32 papers, 749 citations indexed

About

Anna Verrone is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Anna Verrone has authored 32 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 15 papers in Immunology and 9 papers in Physiology. Recurrent topics in Anna Verrone's work include Psoriasis: Treatment and Pathogenesis (14 papers), Dermatology and Skin Diseases (11 papers) and Asthma and respiratory diseases (9 papers). Anna Verrone is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (14 papers), Dermatology and Skin Diseases (11 papers) and Asthma and respiratory diseases (9 papers). Anna Verrone collaborates with scholars based in Italy, Switzerland and Belarus. Anna Verrone's co-authors include Pietro Quaglino, Paola Savoia, Amedeo Lonardo, Nicola Carulli, Paola Loria, Marco Bertolotti, M.G. Bernengo, Lucia Carulli, Alberto Bagni and D. Ganazzi and has published in prestigious journals such as Journal of Hepatology, Journal of Investigative Dermatology and British Journal of Dermatology.

In The Last Decade

Anna Verrone

31 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Verrone Italy 15 381 267 224 179 144 32 749
G Tessari Italy 8 270 0.7× 333 1.2× 98 0.4× 603 3.4× 25 0.2× 8 994
Susana Armesto Spain 15 128 0.3× 184 0.7× 115 0.5× 407 2.3× 18 0.1× 56 772
Jūratė Kondrackienė Lithuania 10 193 0.5× 125 0.5× 39 0.2× 41 0.2× 33 0.2× 13 818
Edith M. Koehler Netherlands 10 891 2.3× 25 0.1× 175 0.8× 124 0.7× 362 2.5× 12 1.1k
Douglas Charney United States 12 243 0.6× 18 0.1× 87 0.4× 38 0.2× 119 0.8× 18 540
Salem Alshemmari Kuwait 14 177 0.5× 97 0.4× 121 0.5× 55 0.3× 9 0.1× 48 575
Shiva Yazdanyar Denmark 13 146 0.4× 304 1.1× 48 0.2× 233 1.3× 18 0.1× 17 752
W.Y. Au China 14 88 0.2× 25 0.1× 157 0.7× 110 0.6× 39 0.3× 37 713
Toru Yoshinari Japan 12 95 0.2× 49 0.2× 71 0.3× 181 1.0× 376 2.6× 20 855
Giuseppe Papa Italy 18 30 0.1× 226 0.8× 176 0.8× 138 0.8× 71 0.5× 36 1.1k

Countries citing papers authored by Anna Verrone

Since Specialization
Citations

This map shows the geographic impact of Anna Verrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Verrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Verrone more than expected).

Fields of papers citing papers by Anna Verrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Verrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Verrone. The network helps show where Anna Verrone may publish in the future.

Co-authorship network of co-authors of Anna Verrone

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Verrone. A scholar is included among the top collaborators of Anna Verrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Verrone. Anna Verrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 51(1). 35–41.
2.
Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of guselkumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 50(8). 1590–1597. 1 indexed citations
3.
Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2024). Clinical characteristics and response to biological therapies for inverse psoriasis: a real‐life comparison between the therapeutic effects of anti‐IL ‐23 and anti‐IL ‐17 agents. International Journal of Dermatology. 63(12). 1735–1739. 3 indexed citations
4.
Mastorino, Luca, Michela Ortoncelli, Chiara Astrua, et al.. (2024). Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis. Journal of Clinical Medicine. 13(21). 6546–6546. 4 indexed citations
5.
Mastorino, Luca, Caterina Cariti, Niccolò Siliquini, et al.. (2023). Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study. Dermatologic Therapy. 2023(1). 2 indexed citations
6.
Mastorino, Luca, Paolo Dapavo, Francesco Leo, et al.. (2023). Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology. 38(3). 568–575. 11 indexed citations
7.
Mastorino, Luca, Paolo Frigatti, Gabriele Roccuzzo, et al.. (2023). Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy. 23(9). 929–936. 10 indexed citations
8.
Giordano, Silvia, Paolo Dapavo, Michela Ortoncelli, et al.. (2023). Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of Clinical Medicine. 12(24). 7503–7503. 7 indexed citations
9.
Mastorino, Luca, Paolo Dapavo, Caterina Cariti, et al.. (2023). Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(1). 34–42. 24 indexed citations
10.
Mastorino, Luca, Caterina Cariti, Anna Verrone, et al.. (2023). Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology. 37(9). 1848–1853. 14 indexed citations
11.
Virgili, Annarosa, Alessandro Borghi, Simone Cazzaniga, et al.. (2020). Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases. Giornale Italiano di Dermatologia e Venereologia. 155(2). 155–160. 12 indexed citations
12.
Carulli, Lucia, Stefano Ballestri, Amedeo Lonardo, et al.. (2011). Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?. Internal and Emergency Medicine. 8(4). 297–305. 65 indexed citations
13.
Loria, Paula M., Amedeo Lonardo, Lucia Carulli, et al.. (2005). Review article: the metabolic syndrome and non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 22(s2). 31–36. 52 indexed citations
14.
Loria, Paola, Amedeo Lonardo, Francesca Leonardi, et al.. (2003). Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates. Digestive Diseases and Sciences. 48(11). 2173–2181. 104 indexed citations
15.
Lonardo, Amedeo, Paola Loria, Anna Verrone, et al.. (2002). Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Digestive and Liver Disease. 34(3). 204–211. 101 indexed citations
16.
Quaglino, Pietro, et al.. (1999). Mycosis fungoides in Patients under 20 Years of Age: Report of 7 Cases, Review of the Literature and Study of the Clinical Course. Dermatology. 199(1). 8–14. 48 indexed citations
17.
Fierro, Maria Teresa, Pietro Quaglino, Paola Savoia, Anna Verrone, & M.G. Bernengo. (1998). Systemic Poly chemotherapy in the Treatment of Primary Cutaneous Lymphomas: a Clinical Follow-Up Study of 81 Patients Treated with COP or CHOP. Leukemia & lymphoma. 31(5-6). 583–588. 44 indexed citations
18.
Savoia, Paola, et al.. (1998). Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis. Journal of Cutaneous Pathology. 25(2). 89–94. 19 indexed citations
19.
20.
Novelli, Mauro, Maria Teresa Fierro, Arianna De Matteis, et al.. (1996). Skin infiltrating lymphocyte flow-cytometric immunophenotyping: automated mechanical biopsy disaggregation and CD45 gating.. Journal of Investigative Dermatology. 107. 166–166. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Tessari Breakdown of academic impact, for papers by Susana Armesto Breakdown of academic impact, for papers by Jūratė Kondrackienė Breakdown of academic impact, for papers by Edith M. Koehler Breakdown of academic impact, for papers by Douglas Charney Breakdown of academic impact, for papers by Salem Alshemmari Breakdown of academic impact, for papers by Shiva Yazdanyar Breakdown of academic impact, for papers by W.Y. Au Breakdown of academic impact, for papers by Toru Yoshinari Breakdown of academic impact, for papers by Giuseppe Papa
Rankless by CCL
2026